Companies / Sofgen Pharma S.A.

Sofgen Pharma S.A.

OTC: PROCCIK 1863362LUXEMBOURG

Financials · FY2024

Revenue$373.80M
Net income$-68.30M
Total debt—
Cash$30.32M
Diluted EPS$-0.68
Shares outstanding112.8M

Ownership

112.8M shares outstanding
100.0%Public float
Ownership
Public float100.00%112,824,183

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Bernal Jaramillo Daniel AugustoDirector
——
Eguiguren AlbertoDirector
——
Garcia Iragorri CarlosDirector
——
Manieu Alexandre WeinsteinDirector · 10% owner
——
Moreira Muniz Fernando SebastianDirector · 10% owner
——
Palacios Luis AlbertoChief Commercial Officer
——
Romero Camacho CarlosDirector
——
Silva Angelini Melissa AndreiaCEOInterim CEO
——
Vial Claro Manuel JoseDirector
——
Weinstein Nicolas AlexandreDirector
——

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
No activity matches these filters.